Cell Counting Kit-8 (CCK-8): Sensitive WST-8 Cell Viability Assay

Executive Summary: The Cell Counting Kit-8 (CCK-8) utilizes WST-8, a water-soluble tetrazolium salt, to quantify viable cells via mitochondrial dehydrogenase activity (ApexBio, 2024). The CCK-8 assay outperforms traditional MTT and XTT assays in sensitivity and procedural simplicity (Xia et al., 2025). Its non-radioactive, colorimetric readout is directly proportional to cell number, facilitating rapid, high-throughput screening. CCK-8 is validated for applications in cancer research, neurodegenerative disease models, and metabolic activity assessment (Rox-Azide, 2022). Benchmarking studies confirm robust performance across diverse cell types and experimental conditions.

Biological Rationale

Accurate measurement of cell viability is essential for evaluating cytotoxicity, proliferation, and metabolic activity in vitro. Traditional assays, such as MTT, XTT, and MTS, often require cell lysis or involve insoluble products, complicating downstream analyses. The Cell Counting Kit-8 (CCK-8) addresses these limitations by using WST-8, which is reduced by cellular dehydrogenases to produce a water-soluble formazan dye. Intracellular dehydrogenase activity is a reliable biomarker of viable, metabolically active cells (Xia et al., 2025). The resulting color intensity correlates linearly with cell number, enabling quantitative assessment without radioactive substrates or complex extraction steps. CCK-8 is thus particularly valuable in high-throughput drug screening, cytotoxicity testing, and disease modeling.

Mechanism of Action of Cell Counting Kit-8 (CCK-8)

The core of the CCK-8 assay is the WST-8 substrate (2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt). Upon addition to living cells, WST-8 is bioreduced by intracellular NAD(P)H-dependent dehydrogenases to form a yellow-orange formazan product. This process is strictly dependent on mitochondrial and cytosolic enzyme activity, ensuring specificity for viable cells. The water-soluble formazan dye accumulates in the culture medium and can be measured directly at 450 nm using a standard microplate reader. The reaction is non-toxic and does not require cell lysis, allowing for subsequent downstream analyses if necessary (Cytochalasin-D, 2023). The mechanism enables real-time kinetic monitoring and multiplexing with other assays.

Evidence & Benchmarks

• CCK-8 detects as few as 100–500 viable cells per well in 96-well plate format, demonstrating superior sensitivity over MTT and WST-1 assays (Xia et al., 2025).
• WST-8-based colorimetric response is linear with cell number up to at least 25,000 cells/well under standard conditions (37°C, 5% CO₂, pH 7.4, 2–4 h incubation) (ApexBio, 2024).
• In murine MLE-12 lung epithelial cells, CCK-8 robustly quantifies viability changes in response to t-BHP-induced oxidative stress, paralleling TUNEL and western blot results (Xia et al., 2025).
• CCK-8 is compatible with serum-free, low-glucose, and high-throughput screening conditions and yields reproducible Z' factors >0.7 (Rox-Azide, 2022).
• Compared to MTT, CCK-8 does not require organic solvents for dye solubilization, reducing cytotoxicity and procedural complexity (AZD3514, 2023).

Applications, Limits & Misconceptions

CCK-8 is widely implemented for:

• Cancer research: Quantifying cell proliferation and cytotoxicity of chemotherapeutic agents.
• Neurodegenerative disease studies: Assessing oxidative stress and metabolic activity in neuronal cultures.
• Cellular metabolic activity: Measuring mitochondrial function and viability in metabolic and toxicological studies.
• Inflammation and regenerative medicine: Monitoring viability in stem cell and immune cell models (Rox-Azide, 2022). This article extends previous discussions by providing validated, cross-assay comparisons and evidence-backed usage constraints.
• High-throughput screening: Enabling rapid, non-radioactive cell-based assays in drug development pipelines.

Common Pitfalls or Misconceptions

• CCK-8 only measures metabolically active cells; non-metabolic but viable cells may be underestimated.
• Reducing agents (e.g., ascorbate, DTT) or high serum levels can artificially increase background, confounding the assay.
• CCK-8 is not suitable for direct quantification of apoptosis or necrosis; complementary assays (e.g., TUNEL, Annexin V) are required for mechanistic insights (Xia et al., 2025).
• Some cell types (e.g., cells with low dehydrogenase activity) may yield weak signals even when viable.
• The assay is not validated for in vivo imaging or tissue-level assessment; it is restricted to in vitro cell cultures.

Workflow Integration & Parameters

To implement the CCK-8 assay, cells are seeded in appropriate density (generally 1,000–25,000 cells/well for 96-well plates) in complete medium. After experimental treatment, 10 µL of CCK-8 solution is added to each well containing 100 µL of medium. Incubation is performed at 37°C (5% CO₂) for 1–4 hours, depending on cell type and metabolic rate. Absorbance is measured at 450 nm using a microplate reader. The formazan dye formed is water-soluble, eliminating the need for additional solubilization steps. Controls (blank, vehicle, positive/negative) are required for accurate normalization. The non-destructive workflow supports further downstream analysis, such as mRNA or protein extraction from the same samples. For further protocol details and troubleshooting, consult the product page and recent reviews (AZD3514, 2023). This article updates previous mechanistic and troubleshooting guidance by incorporating latest benchmarking data across disease and metabolic models.

Conclusion & Outlook

Cell Counting Kit-8 (CCK-8) offers an efficient, sensitive, and user-friendly platform for cell viability, proliferation, and cytotoxicity assessment in vitro. Its WST-8-based chemistry supports high-throughput screening and minimizes assay-related cytotoxicity. Benchmarking studies confirm robust linearity, reproducibility, and compatibility with multiple cell types and experimental formats. While not suitable for apoptosis-specific or in vivo assays, CCK-8 is a gold standard for routine cell viability measurement in biomedical and pharmaceutical research. For extended mechanistic and translational applications, see related reviews—this article provides updated, evidence-based guidance for integrating CCK-8 into next-generation workflows.